Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer

The EphA2 receptor tyrosine kinase is overexpressed in a variety of human epithelial cancers and is a determinant of malignant cellular behavior in pancreatic adenocarcinoma cells. Moreover, it is expressed in tumor endothelium and its activation promotes angiogenesis. To better clarify the therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansuini, Helenia, Meola, Annalisa, Gunes, Zeynep, Paradisi, Valentina, Pezzanera, Monica, Acali, Stefano, Santini, Claudia, Luzzago, Alessandra, Mori, Federica, Lazzaro, Domenico, Ciliberto, Gennaro, Nicosia, Alfredo, La Monica, Nicola, Vitelli, Alessandra
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814375/
https://www.ncbi.nlm.nih.gov/pubmed/20130824
http://dx.doi.org/10.1155/2009/951917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814375/
https://www.ncbi.nlm.nih.gov/pubmed/20130824
http://dx.doi.org/10.1155/2009/951917

Ejemplares similares